EUROPIN

Trencin, Slovakia Founded: 1997 • Age: 29 yrs Acquired By Gilde Healthcare
Pen cannulas and lancet needles are manufactured for medical sectors.

About EUROPIN

EUROPIN is a Healthcare company based in Trencin (Slovakia) founded in 1997, and was acquired by Gilde Healthcare in February 2022. Pen cannulas and lancet needles are manufactured for medical sectors. Its chief executive, as recorded, is Lothar Lindenau. Its focus areas include Traditional Medical Devices.

Company details

EUROPIN was established in 1997 and is based in Trencin, Slovakia. Manufacturing operations focus on pen cannulas and lancet needles, which are produced for use in the medical and pharmaceutical industries. The company serves these sectors through specialized needle production, with activities centered in its Slovakian facility. Leadership is provided by CEO Lothar Lindenau, overseeing core production processes.

  • Headquarters Trencin, Slovakia
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website europin.sk
  • Acquired by Gilde Healthcare (Feb 2022)
Key Metrics

Investors in EUROPIN

EUROPIN has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Gilde Healthcare.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Private equity and venture captial firm focused on healthcare sectors
gildehealthcare.comCambridge, United States
Premium access

Investor details for EUROPIN

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of EUROPIN

1 people are tracked at EUROPIN (1 in leadership).

NameRoleGroup
Lothar Lindenau
CEOLeadership
Premium access

Complete people profiles for EUROPIN

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of EUROPIN

2 dated milestones of EUROPIN across 25 years, from founding to its latest funding, stage changes and deals.

  1. Founded EUROPIN is founded.
  2. Exit Acquired by Gilde Healthcare.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about EUROPIN

EUROPIN was founded in 1997.

EUROPIN is headquartered in Trencin, Slovakia.

Lothar Lindenau is the CEO of EUROPIN, as recorded in our data.

EUROPIN was established in 1997 and is based in Trencin, Slovakia. Manufacturing operations focus on pen cannulas and lancet needles, which are produced for use in the medical and pharmaceutical industries. The company serves these sectors through specialized needle production, with activities centered in its Slovakian facility. Leadership is provided by CEO Lothar Lindenau, overseeing core production processes.

EUROPIN has 1 investor. Key investors include Gilde Healthcare.

Yes. EUROPIN was acquired by Gilde Healthcare in February 2022.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available